Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice Larosa

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Haematologica|August 4, 2006
Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter studyJean-François Abgrall, Isabelle Guibaud, Jean-Noël Bastie, et al.
Leukemia Research|May 25, 2023
First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemiaMarie Balsat, Vincent Alcazer, Gabriel Etienne, et al.
Blood|February 11, 2012
Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS studyBruno Lioure, Marie C Béné, Arnaud Pigneux, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 12, 2009
Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie CellulaireAnne Sirvent, Nathalie Dhedin, Mauricette Michallet, et al.
Emerging Infectious Diseases|May 23, 2024
Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal Infections, FranceCarole Vignals, Joseph Emmerich, Hugues Begueret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2019
Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML PatientsFranck Emmanuel Nicolini, Stéphanie Dulucq, Lisa Boureau, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Haematologica|August 4, 2006
Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter studyJean-François Abgrall, Isabelle Guibaud, Jean-Noël Bastie, et al.
Leukemia Research|May 25, 2023
First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemiaMarie Balsat, Vincent Alcazer, Gabriel Etienne, et al.
Blood|February 11, 2012
Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS studyBruno Lioure, Marie C Béné, Arnaud Pigneux, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 12, 2009
Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie CellulaireAnne Sirvent, Nathalie Dhedin, Mauricette Michallet, et al.
Emerging Infectious Diseases|May 23, 2024
Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal Infections, FranceCarole Vignals, Joseph Emmerich, Hugues Begueret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2019
Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML PatientsFranck Emmanuel Nicolini, Stéphanie Dulucq, Lisa Boureau, et al.
Pageof 4